Ionis Pharmaceuticals, Inc.
IONS
$75.83
$0.450.60%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 28.61% | 15.97% | 28.56% | 26.67% | -19.04% |
| Total Depreciation and Amortization | 13.84% | 3.20% | -7.68% | -3.66% | -3.58% |
| Total Amortization of Deferred Charges | 14.25% | 3.26% | -0.99% | -0.93% | 2.37% |
| Total Other Non-Cash Items | -6.57% | 0.57% | 5.03% | 23.19% | 32.85% |
| Change in Net Operating Assets | -260.98% | 75.54% | -1.06% | -7.11% | -202.53% |
| Cash from Operations | -81.48% | 46.38% | 29.81% | 33.36% | -55.13% |
| Capital Expenditure | -13.62% | -13.61% | -193.45% | -393.28% | -199.36% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 989.88% | -155.03% | 226.48% | -184.50% | -93.34% |
| Cash from Investing | 323.29% | -107.25% | 191.70% | -223.06% | -121.15% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -499.49% | -499.53% | -27,136.59% | 34.25% | 90.85% |
| Issuance of Common Stock | -50.60% | -63.15% | -84.87% | 607.32% | 611.24% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 60.04% | 41.37% | -92.80% | 1,216.73% | 160.12% |
| Foreign Exchange rate Adjustments | 354.79% | 357.14% | -52.30% | 1,585.37% | -45.52% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.22% | 182.82% | 121.40% | 102.53% | -312.50% |